Abstract
Vertebrate genomes contain proto-oncogenes whose enhanced expression or alteration by mutation seems to be involved in the development of naturally occurring tumours1,2. These activated genes, usually assayed by their ability to induce the malignant transformation of NIH 3T3 cells, are frequently related to the ras oncogene3–10 of Harvey (Ha-ras)11 or Kirsten (Ki-ras)12 murine sarcoma viruses, or a third member of this family (N-ras)13–15. Activation involves point mutation which often affect codon 12 (refs 16–26) of the encoded 21,000-molecular weight polypeptide (p21). To provide insight into structural requirements involved in p21 activation, we have now constructed 20 mutant c-Ha-ras1 genes by in vitro mutagenesis, each encoding a different amino acid at codon 12. Analysis of rat fibroblasts transfected with these altered genes demonstrates that all amino acids except glycine (which is encoded by normal cellular ras genes) and proline at position 12 activate p21, suggesting a requirement for an α-helical structure in this region of the polypeptide. The morphological phenotype of cells transformed by the activated genes can, however, depend on the particular amino acid at this position.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bishop, J. M. A. Rev. Biochem. 52, 310–354 (1983).
Land, H., Parada, L. F. & Weinberg, R. A. Science 222, 771–778 (1983).
Der, C.J., Krontiris, T. G. & Cooper, G. M. Proc. natn. Acad. Sci. U.S.A. 79, 3637–3640 (1982).
Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Nature 297, 474–478 (1982).
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S. & Barbacid, M. Nature 298, 343–347 (1982).
Pulciani, S. et al. Nature 300, 539–542 (1982).
McCoy, M. S. et al. Nature 302, 79–81 (1983).
Shimizu, K. et al. Proc. natn. Acad. Sci. U.S.A. 80, 2112–2116 (1983).
Eva, A., Tronick, S. R., Gol, R. A., Pierce, J. H. & Aaronson, S. A. Proc. natn. Acad. Sci. U.S.A. 80, 4926–4930 (1983).
Fujita, J. et al. Nature 309, 464–466 (1984).
Dhar, R. et al. Science 217, 934–936 (1982).
Tsuchida, N., Ryder, T. & Ohtsubo, E. Science 217, 937–939 (1982).
Hall, A., Marshall, C. J., Spurr, N. K. & Weiss, R. A. Nature 303, 396–400 (1983).
Murray, M. et al. Cell 33, 749–757 (1983).
Taparowsky, E., Shimizu, K., Goldfarb, M. & Wigler, M. Cell 34, 581–586 (1983).
Tabin, C. J. et al. Nature 300, 143–149 (1982).
Reddy, E. P., Reynolds, R. K., Santos, E. & Barbacid, M. Nature 300, 149–152 (1982).
Taparowsky, E. et al. Nature 300, 762–765 (1982).
Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H. & Goeddel, D. V. Nature 302, 33–37 (1983).
Shimizu, K. et al. Nature 304, 497–500 (1983).
Capon, D. J. et al. Nature 304, 507–513 (1983).
Santos, E., Reddy, E. J., Pulciani, S., Feldman, R. J. & Barbacid, M. Proc. natn. Acad. Sci. U.S.A. 80, 4679–4683 (1983).
Nakano, H. et al. Proc. natn. Acad. Sci. U.S.A. 81, 71–75 (1984).
Santos, E. et al. Science 223, 661–664 (1984).
Sukumar, S., Notario, V., Martin-Zanca, D. & Barbacid, M. Nature 306, 658–661 (1983).
Rasheed, S., Norman, G. L. & Heidecker, G. Science 221, 155–157 (1983).
Messing, J. & Vieira, J. Gene 19, 264–276 (1982).
Zoller, M. J. & Smith, M. Nucleic Acids Res. 10, 6487–6500 (1982).
Crea, R. & Horn, T. Nucleic Acids Res. 8, 2331–2348 (1980).
Chang, E. H., Furth, M. E., Scolnick, E. M. & Lowy, D. R. Nature 297, 479–483 (1982).
Freeman, A. E. Proc. natn. Acad. Sci. U.S.A. 70, 2415–2419 (1973).
Colbere-Garapin, F., Horodniceanu, F., Kourilsky, P. & Garapin, A.-C. J. molec. Biol. 150, 1–14 (1981).
Southern, P. J. & Berg, P. J. molec. appl. Genet. 1, 327–341 (1982).
Wigler, M. et al. Cell 16, 777–785 (1979).
Perucho, M., Hanahan, D. & Wigler, M. Cell. 22, 309–317 (1980).
McGrath, J. P., Capon, D. J., Goeddel, D. V. & Levinson, A. D. Nature 310, 644–649 (1984).
Der, C. J. & Cooper, G. M. Cell 32, 201–208 (1983).
Feig, L. A., Bast, R. C., Knapp, R. C. & Cooper, G. M. Science 223, 698–701 (1984).
Fasano, O. et al. Proc. natn. Acad. Sci. U.S.A. 81, 4008–4012 (1984).
Pincus, M. R. et al. Proc. natn. Acad. Sci. U.S.A. 80, 5253–5257 (1983).
Chou, P. Y. & Fassman, G. D. Biochemistry 13, 222–245 (1974).
Shih, T. Y. et al. J. Virol. 42, 253–261 (1982).
Papageorge, A., Lowy, D. & Scolnick, E. J. Virol. 44, 509–519 (1982).
Finkel, T., Der, C. J. & Cooper, G. M. Cell 37, 151–158 (1984).
Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977).
Messing, J., Crea, R. & Seeburg, P. H. Nucleic Acids Res. 9, 309–321 (1981).
Sanger, F. et al. J. molec. Biol. 143, 161–178 (1980).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Wigler, M. et al. Proc. natn. Acad. Sci. U.S.A. 76, 1373–1376 (1979).
Tooze, J. (ed.) DNA Tumor viruses: Molecular Biology of Tumor Viruses Pt 2 (Cold Spring Harbor Laboratory, New York, 1981).
Kaplan, P. L., Topp, W. C. & Ozanne, B. Virology 108, 484–490 (1981).
Laemmli, U. K. Nature 227, 680–685 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seeburg, P., Colby, W., Capon, D. et al. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature 312, 71–75 (1984). https://doi.org/10.1038/312071a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/312071a0
This article is cited by
-
Restricting epigenetic activity promotes the reprogramming of transformed cells to pluripotency in a line-specific manner
Cell Death Discovery (2023)
-
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
Journal of Experimental & Clinical Cancer Research (2022)
-
A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation
Inflammation and Regeneration (2022)
-
Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
Nature Chemical Biology (2022)
-
Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
Scientific Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.